Combinent Biomedical Systems, a women's healthcare company, has been empowering women's health since their establishment in 2000. They are known for their advanced multi-segmented vaginal rings designed for the targeted delivery of hydrophobic and hydrophilic molecules, proteins, and other large molecules. The company focuses on transvaginal delivery of medications for women's reproductive endocrinology disorders, diabetes, obesity, and infectious diseases. Headquartered in Lexington, Massachusetts, Combinent Biomedical Systems received a significant $600.00K Venture Round investment on 02 October 2012. This innovative startup operates in the Biotechnology, Health Care, and Women's Health industries, offering promising potential for both investors and the improvement of women's healthcare.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $600.00K | - | 02 Oct 2012 | |
Debt Financing | $750.00K | - | 04 Jan 2012 | |
Venture Round | $1.00M | - | 29 Dec 2010 | |
Debt Financing | $500.00K | - | 29 Sep 2010 | |
Venture Round | $500.00K | 3 | Cytyc, Commons Capital | 17 Dec 2009 |
No recent news or press coverage available for Combinent Biomedical Systems.